Teleflex Could See 'Muted' Business Through Business Separation in Mid-2026, RBC Says

MT Newswires Live
2025/03/01

Teleflex (TFX) could see "muted" business through the completion of its planned separation in mid-2026, RBC Capital Martkets said in a Friday note.

On Thursday, Teleflex said its board approved a plan to separate the Urology, Acute Care, and OEM segments into a publicly traded company.

The company announced the separation the same day it released its Q4 results and issued guidance for 2025. Teleflex reported Q4 adjusted earnings from continuing operations of $3.89 per diluted share and $795.4 million in revenue, and guided 2025 adjusted EPS at $13.95 to $14.35.

According RBC, the Q4 top-line miss, disappointing 2025 revenue growth outlook, and business separation plan raise questions over Teleflex's current business state. The company also faces potential headwind from new US tariffs, the investment firm added.

"We view TFX's new strategic direction favorably, but believe it'll be sometime before it begins to drive shareholder value," RBC said.

RBC downgraded Teleflex to sector perform from outperform, with a lower price target of $155 from $220 previously.

Price: 134.98, Change: -4.13, Percent Change: -2.97

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10